Completed PHASE4 INTERVENTIONAL 2-arm NCT03955575

Treatment of Bile Acid Malabsorption With Liraglutide (BAM-LIRA)

Sponsor: Filip Krag Knop

Interventions Colesevelam Liraglutide 6 MG/ML

Updated 9 times since 2019 Last updated: Jun 1, 2022 Started: Mar 7, 2019 Primary completion: Mar 10, 2021 Completion: May 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Bile Acid Malabsorption and is currently completed. Filip Krag Knop leads this study, which shows 9 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jul 2022 — Jul 2024 [monthly]

Completed PHASE4

Status: Recruiting → Completed
Jun 2021 — Jul 2022 [monthly]

Recruiting PHASE4
Jan 2021 — Jun 2021 [monthly]

Recruiting PHASE4

▶ Show 4 earlier versions

Jul 2020 — Jan 2021 [monthly]

Recruiting PHASE4
Jun 2020 — Jul 2020 [monthly]

Recruiting PHASE4
Sep 2019 — Jun 2020 [monthly]

Recruiting PHASE4
Jun 2019 — Sep 2019 [monthly]

Recruiting PHASE4

First recorded

Mar 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Filip Krag Knop
Herlev and Gentofte Hospital

Data source: University Hospital, Gentofte, Copenhagen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hellerup, Denmark